Insights

Target Market Fit European medtech player focused on electrical heart therapy and vascular intervention suggests opportunities with hospital systems and referral networks in Europe, especially for balloon-expandable cobalt chromium iliac stents and related device adoptions.

Product Innovation Recent launch of next-generation Dynetic-35 iliac stent indicates openness to advanced, patient-specific solutions; sales potential in expanding flagship product lines and cross-selling complementary vascular devices.

Scale Gap Smaller revenue (<$1M) and employee range 501-1000 imply a growth phase; potential to upsell integrated service contracts, training programs, and data analytics solutions to optimize implant procedures.

Tech Momentum Tech stack showing modern web and collaboration tools (Vue.js, three.js, Microsoft 365) points to readiness for digital engagement, virtual demonstrations, and online training platforms for clinicians.

Competitive Position Presence among global players with 5x growth in market segments and targeted vascular/interventional focus suggests value in partnership-led expansions, distributor alliances, and regional clinical studies to differentiate offerings.

Similar companies to Teleflex / Vascular Intervention Biotronik AG

Teleflex / Vascular Intervention Biotronik AG Tech Stack

Teleflex / Vascular Intervention Biotronik AG uses 7 technology products and services including Microsoft 365, Element UI, Vue.js, and more. Explore Teleflex / Vascular Intervention Biotronik AG's tech stack below.

  • Element UI
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • Office Suites
  • three.js
    Programming Languages
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Teleflex / Vascular Intervention Biotronik AG's Email Address Formats

Teleflex / Vascular Intervention Biotronik AG uses at least 5 email formats:
Teleflex / Vascular Intervention Biotronik AG Email FormatsExamplePercentage
First.Last@biotronik.comJohn.Doe@biotronik.com
96%
FirstLast@biotronik.comJohnDoe@biotronik.com
2%
First.Middle@biotronik.comJohn.Michael@biotronik.com
1%
LastF@biotronik.comDoeJ@biotronik.com
1%
First.Last@biotronik.chJohn.Doe@biotronik.ch
100%

Frequently Asked Questions

What is Teleflex / Vascular Intervention Biotronik AG's official website and social media links?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's official website is biotronik.ch and has social profiles on LinkedIn.

How much revenue does Teleflex / Vascular Intervention Biotronik AG generate?

Minus sign iconPlus sign icon
As of July 2026, Teleflex / Vascular Intervention Biotronik AG's annual revenue is estimated to be <$1M.

What is Teleflex / Vascular Intervention Biotronik AG's NAICS code?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Teleflex / Vascular Intervention Biotronik AG have currently?

Minus sign iconPlus sign icon
As of July 2026, Teleflex / Vascular Intervention Biotronik AG has approximately 501 employees across 2 continents, including Europe and North America. Key team members include Head Of Customer Service & Sales Support: A. V., Managing Director: M. A. and Director Strategy & Project Portfolio Management: N. L. Explore Teleflex / Vascular Intervention Biotronik AG's employee directory with LeadIQ.

What industry does Teleflex / Vascular Intervention Biotronik AG belong to?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG operates in the Medical Equipment Manufacturing industry.

What technology does Teleflex / Vascular Intervention Biotronik AG use?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's tech stack includes Microsoft 365, Element UI, Vue.js, Office 365, three.js, Apache and Apache HTTP Server.

What is Teleflex / Vascular Intervention Biotronik AG's email format?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's email format typically follows the pattern of First.Last@biotronik.com. Find more Teleflex / Vascular Intervention Biotronik AG email formats with LeadIQ.
Teleflex / Vascular Intervention Biotronik AG logo

Teleflex / Vascular Intervention Biotronik AG

Medical Equipment ManufacturingRhineland-palatinate, Germany501-1000 Employees

Teleflex / Vascular Intervention Biotronik AG is a European medical technology company in the medical equipment manufacturing industry. The organization focuses on two business areas: cardiac electrotherapy and vascular intervention, developing devices to support clinicians in treating patients. The company is located at 4 Neuhofstrasse Baar, Rhineland-palatinate, Germany, and employs between 501 and 1000 people. Its website is https://biotronik.ch. In 2020, Biotronik Schweiz AG announced the availability of its next-generation balloon-expandable cobalt chromium iliac stent system, Dynetic-35, reflecting ongoing product development in vascular intervention. Revenue is reported in the range of $0–1 million.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • <$1M

    Teleflex / Vascular Intervention Biotronik AG's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.